Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Researchers Develop Analytical ...
Smart watches and wearable ... offered to patients recovering from strokes to assess their gait and mobility, with smart watches to monitor tremors in patients with Parkinson’s disease.
Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...
One important part of virtual care will be integrating the use of wearable technologies with AI systems ... management of conditions such as Parkinson’s disease. On the horizon are even more ...
Alimetry has raised an oversubscribed US $18m A2 financing round to commercialize its wearable gut health monitoring device ... journey is slow and poor for patients, causing them to suffer ...
AbbVie made history in 2015 with its Parkinson’s disease infusion pump therapy Duopa, kicking off a trend of delivery system innovation in the space as drugmakers sought to avoid the common ...
Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...
The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...
Parkinson’s disease (PD) is a progressive disorder of the nervous system. It primarily affects movement but can also lead to other symptoms, significantly impacting quality of life over time.
In an attempt to improve job sites, researchers have designed a system of wearable sensors that rely on machine learning to monitor workers for signs of physical strain and tiredness. In doing so ...
A million Americans have Parkinson’s disease, and that number is expected to increase to 1.2 million by 2030. Most of those afflicted are between 75 and 85, but 4% are under 50. The cause is still ...